| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Neoplasms | 46 | 2024 | 2525 | 4.390 |
Why?
|
| Soft Tissue Neoplasms | 39 | 2024 | 1154 | 4.260 |
Why?
|
| Chordoma | 26 | 2023 | 346 | 3.820 |
Why?
|
| Sarcoma | 40 | 2023 | 1791 | 3.770 |
Why?
|
| Chondrosarcoma | 9 | 2023 | 296 | 2.180 |
Why?
|
| RNA-Binding Protein EWS | 14 | 2024 | 210 | 2.090 |
Why?
|
| Liposarcoma | 7 | 2020 | 285 | 1.970 |
Why?
|
| Osteosarcoma | 15 | 2024 | 896 | 1.930 |
Why?
|
| Giant Cell Tumor of Bone | 8 | 2022 | 117 | 1.740 |
Why?
|
| Bone Cysts, Aneurysmal | 3 | 2022 | 70 | 1.700 |
Why?
|
| Chondroblastoma | 6 | 2020 | 48 | 1.580 |
Why?
|
| Rhabdomyosarcoma | 5 | 2022 | 358 | 1.520 |
Why?
|
| Fibrosarcoma | 5 | 2023 | 308 | 1.490 |
Why?
|
| Myoepithelioma | 4 | 2019 | 26 | 1.320 |
Why?
|
| Lipoma | 6 | 2020 | 292 | 1.260 |
Why?
|
| Gene Fusion | 7 | 2022 | 354 | 1.250 |
Why?
|
| Vulvar Neoplasms | 9 | 2022 | 263 | 1.230 |
Why?
|
| Chondroma | 4 | 2020 | 53 | 1.140 |
Why?
|
| Osteoblastoma | 2 | 2022 | 24 | 1.090 |
Why?
|
| Joint Diseases | 3 | 2021 | 459 | 0.990 |
Why?
|
| Uterine Neoplasms | 7 | 2023 | 1420 | 0.990 |
Why?
|
| Immunohistochemistry | 49 | 2024 | 11070 | 0.990 |
Why?
|
| Spinal Neoplasms | 11 | 2018 | 715 | 0.890 |
Why?
|
| Cell Dedifferentiation | 3 | 2020 | 122 | 0.880 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 3 | 2020 | 367 | 0.860 |
Why?
|
| Pelvic Neoplasms | 2 | 2022 | 247 | 0.820 |
Why?
|
| NFATC Transcription Factors | 2 | 2021 | 389 | 0.780 |
Why?
|
| Bone Cysts | 1 | 2021 | 48 | 0.740 |
Why?
|
| Knee Joint | 4 | 2018 | 1673 | 0.720 |
Why?
|
| Sarcoma, Clear Cell | 3 | 2022 | 72 | 0.710 |
Why?
|
| Epithelioid Cells | 5 | 2020 | 60 | 0.700 |
Why?
|
| Hemangiosarcoma | 7 | 2023 | 215 | 0.690 |
Why?
|
| In Situ Hybridization | 3 | 2020 | 1900 | 0.680 |
Why?
|
| Gene Rearrangement | 8 | 2021 | 1125 | 0.680 |
Why?
|
| Neurofibrosarcoma | 1 | 2019 | 27 | 0.670 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2024 | 455 | 0.660 |
Why?
|
| Leiomyosarcoma | 4 | 2022 | 422 | 0.660 |
Why?
|
| Humerus | 2 | 2021 | 272 | 0.650 |
Why?
|
| Sarcoma, Synovial | 6 | 2023 | 152 | 0.640 |
Why?
|
| Receptors, Calcitriol | 1 | 2021 | 360 | 0.640 |
Why?
|
| In Situ Hybridization, Fluorescence | 15 | 2024 | 2509 | 0.640 |
Why?
|
| Fibula | 1 | 2021 | 266 | 0.630 |
Why?
|
| Myxoma | 3 | 2013 | 114 | 0.620 |
Why?
|
| Mucin-4 | 2 | 2014 | 33 | 0.610 |
Why?
|
| Synovial Cyst | 1 | 2018 | 35 | 0.600 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 6 | 2014 | 696 | 0.570 |
Why?
|
| Diagnosis, Differential | 30 | 2024 | 12969 | 0.550 |
Why?
|
| Carcinoma | 3 | 2021 | 2328 | 0.530 |
Why?
|
| Spine | 3 | 2018 | 1118 | 0.520 |
Why?
|
| Neoplasms, Radiation-Induced | 4 | 2019 | 549 | 0.520 |
Why?
|
| Middle Aged | 117 | 2023 | 220382 | 0.520 |
Why?
|
| Cell Differentiation | 12 | 2023 | 11526 | 0.500 |
Why?
|
| Female | 145 | 2024 | 391875 | 0.500 |
Why?
|
| Adult | 120 | 2023 | 220781 | 0.490 |
Why?
|
| Humans | 213 | 2024 | 760437 | 0.480 |
Why?
|
| Fibroma | 4 | 2018 | 190 | 0.480 |
Why?
|
| Femur | 2 | 2021 | 1308 | 0.480 |
Why?
|
| S100 Proteins | 8 | 2022 | 218 | 0.480 |
Why?
|
| Calmodulin-Binding Proteins | 6 | 2019 | 232 | 0.470 |
Why?
|
| Oncogene Proteins, Fusion | 9 | 2024 | 1605 | 0.470 |
Why?
|
| Sacrum | 4 | 2018 | 276 | 0.470 |
Why?
|
| Neoplasm Recurrence, Local | 18 | 2023 | 9267 | 0.460 |
Why?
|
| Meningeal Neoplasms | 2 | 2022 | 1248 | 0.460 |
Why?
|
| Extremities | 9 | 2014 | 867 | 0.460 |
Why?
|
| Nerve Sheath Neoplasms | 6 | 2021 | 168 | 0.450 |
Why?
|
| Male | 136 | 2024 | 360035 | 0.450 |
Why?
|
| Synovial Membrane | 3 | 2018 | 532 | 0.440 |
Why?
|
| Hemangioma | 3 | 2023 | 727 | 0.440 |
Why?
|
| Aged | 89 | 2023 | 168840 | 0.440 |
Why?
|
| Meningioma | 2 | 2022 | 1218 | 0.440 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2015 | 726 | 0.420 |
Why?
|
| Bone Diseases | 2 | 2021 | 419 | 0.420 |
Why?
|
| Mutation | 15 | 2023 | 30025 | 0.400 |
Why?
|
| Young Adult | 47 | 2023 | 59068 | 0.390 |
Why?
|
| Tongue Neoplasms | 1 | 2013 | 183 | 0.390 |
Why?
|
| Keratins | 5 | 2010 | 497 | 0.380 |
Why?
|
| Oncogene Fusion | 3 | 2020 | 81 | 0.380 |
Why?
|
| Sciatic Nerve | 1 | 2014 | 614 | 0.370 |
Why?
|
| Hashimoto Disease | 1 | 2012 | 105 | 0.370 |
Why?
|
| Paranasal Sinus Neoplasms | 2 | 2007 | 242 | 0.360 |
Why?
|
| Giant Cell Tumors | 4 | 2015 | 89 | 0.360 |
Why?
|
| Polyethylenes | 3 | 2018 | 290 | 0.360 |
Why?
|
| Histiocytosis, Sinus | 1 | 2010 | 45 | 0.350 |
Why?
|
| Genital Neoplasms, Female | 3 | 2022 | 532 | 0.350 |
Why?
|
| Neurilemmoma | 4 | 2021 | 523 | 0.350 |
Why?
|
| RNA-Binding Protein FUS | 3 | 2020 | 75 | 0.350 |
Why?
|
| Transcription Factors | 8 | 2021 | 12121 | 0.330 |
Why?
|
| Plasma Cells | 2 | 2012 | 599 | 0.330 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2021 | 3631 | 0.320 |
Why?
|
| Adolescent | 50 | 2023 | 88196 | 0.320 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2010 | 148 | 0.320 |
Why?
|
| Osteoma, Osteoid | 2 | 2007 | 90 | 0.310 |
Why?
|
| Sarcoma, Small Cell | 2 | 2022 | 17 | 0.310 |
Why?
|
| Ovarian Neoplasms | 6 | 2019 | 4879 | 0.310 |
Why?
|
| Thyroid Gland | 2 | 2012 | 1168 | 0.310 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 2010 | 118 | 0.300 |
Why?
|
| Neurofibromatosis 1 | 4 | 2019 | 560 | 0.300 |
Why?
|
| Aged, 80 and over | 36 | 2021 | 58859 | 0.300 |
Why?
|
| Skull | 2 | 2014 | 818 | 0.300 |
Why?
|
| Mandibular Neoplasms | 2 | 2010 | 130 | 0.300 |
Why?
|
| Comparative Genomic Hybridization | 4 | 2019 | 473 | 0.300 |
Why?
|
| Prognosis | 21 | 2023 | 29551 | 0.290 |
Why?
|
| Perivascular Epithelioid Cell Neoplasms | 2 | 2018 | 77 | 0.290 |
Why?
|
| Actins | 7 | 2020 | 2049 | 0.280 |
Why?
|
| Angiomyoma | 2 | 1997 | 11 | 0.280 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2013 | 929 | 0.280 |
Why?
|
| Disease-Free Survival | 8 | 2023 | 6813 | 0.280 |
Why?
|
| Nose Neoplasms | 1 | 2009 | 249 | 0.270 |
Why?
|
| Desmin | 4 | 2020 | 99 | 0.270 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 3 | 2014 | 104 | 0.260 |
Why?
|
| DNA-Binding Proteins | 6 | 2022 | 9598 | 0.260 |
Why?
|
| Solitary Fibrous Tumors | 2 | 2022 | 67 | 0.260 |
Why?
|
| Skull Base Neoplasms | 3 | 2023 | 270 | 0.260 |
Why?
|
| Translocation, Genetic | 5 | 2019 | 1388 | 0.260 |
Why?
|
| Immunoglobulin G | 3 | 2012 | 4549 | 0.250 |
Why?
|
| Collagen | 5 | 2010 | 2637 | 0.250 |
Why?
|
| Pathology, Clinical | 2 | 2022 | 375 | 0.250 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 2 | 2018 | 100 | 0.250 |
Why?
|
| Gene Expression Regulation, Neoplastic | 13 | 2024 | 8519 | 0.250 |
Why?
|
| Notochord | 3 | 2023 | 37 | 0.240 |
Why?
|
| Sarcoma, Alveolar Soft Part | 2 | 2014 | 43 | 0.240 |
Why?
|
| Retroperitoneal Neoplasms | 5 | 2010 | 332 | 0.240 |
Why?
|
| beta Catenin | 4 | 2024 | 1040 | 0.240 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2005 | 43 | 0.240 |
Why?
|
| Liposarcoma, Myxoid | 3 | 2014 | 60 | 0.240 |
Why?
|
| Biopsy | 12 | 2022 | 6765 | 0.240 |
Why?
|
| Desmoplastic Small Round Cell Tumor | 1 | 2024 | 33 | 0.240 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2016 | 2821 | 0.230 |
Why?
|
| Thyroid Neoplasms | 2 | 2015 | 2331 | 0.230 |
Why?
|
| Gene Deletion | 4 | 2019 | 2667 | 0.230 |
Why?
|
| Adenocarcinoma | 5 | 2019 | 6330 | 0.230 |
Why?
|
| RNA-Binding Proteins | 4 | 2014 | 1897 | 0.230 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2013 | 2052 | 0.220 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 84 | 0.220 |
Why?
|
| Thoracic Vertebrae | 3 | 2018 | 595 | 0.220 |
Why?
|
| Neoplasms, Multiple Primary | 3 | 2017 | 590 | 0.220 |
Why?
|
| Carcinoma, Papillary | 3 | 2015 | 784 | 0.220 |
Why?
|
| Myositis Ossificans | 1 | 2024 | 77 | 0.220 |
Why?
|
| Hemangiopericytoma | 3 | 2008 | 71 | 0.220 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2021 | 4509 | 0.210 |
Why?
|
| Bone and Bones | 3 | 2022 | 2566 | 0.210 |
Why?
|
| Cell Nucleus | 6 | 2016 | 2906 | 0.210 |
Why?
|
| Fibromatosis, Aggressive | 1 | 2024 | 125 | 0.210 |
Why?
|
| Peripheral Nervous System Neoplasms | 2 | 2017 | 133 | 0.210 |
Why?
|
| Neoadjuvant Therapy | 5 | 2022 | 2821 | 0.210 |
Why?
|
| Leiomyoma | 3 | 2023 | 636 | 0.210 |
Why?
|
| Microscopy, Electron, Transmission | 3 | 2010 | 696 | 0.200 |
Why?
|
| Cyclin D1 | 1 | 2024 | 451 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2019 | 310 | 0.200 |
Why?
|
| Histiocytoma, Malignant Fibrous | 2 | 2014 | 55 | 0.200 |
Why?
|
| Receptors, Steroid | 1 | 2022 | 156 | 0.200 |
Why?
|
| Chromosome Deletion | 2 | 2019 | 1387 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 17 | 2024 | 36362 | 0.200 |
Why?
|
| Hemangioendothelioma | 2 | 2016 | 111 | 0.200 |
Why?
|
| Osteolysis, Essential | 2 | 2015 | 30 | 0.200 |
Why?
|
| Bone Density Conservation Agents | 2 | 2021 | 795 | 0.200 |
Why?
|
| Peritoneal Neoplasms | 3 | 2022 | 711 | 0.200 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2023 | 2911 | 0.200 |
Why?
|
| Head and Neck Neoplasms | 2 | 2015 | 2891 | 0.190 |
Why?
|
| Vitamin E | 2 | 2018 | 871 | 0.190 |
Why?
|
| Pathology, Surgical | 2 | 2014 | 151 | 0.190 |
Why?
|
| Child, Preschool | 15 | 2023 | 42209 | 0.190 |
Why?
|
| Vimentin | 4 | 2013 | 255 | 0.190 |
Why?
|
| Dendritic Cell Sarcoma, Follicular | 1 | 2021 | 30 | 0.190 |
Why?
|
| Monitoring, Immunologic | 1 | 2021 | 98 | 0.190 |
Why?
|
| Kidney Neoplasms | 4 | 2015 | 4241 | 0.190 |
Why?
|
| Genes, Neoplasm | 2 | 2014 | 370 | 0.180 |
Why?
|
| Neoplasms, Muscle Tissue | 2 | 2000 | 67 | 0.180 |
Why?
|
| Hyaline Cartilage | 1 | 2020 | 9 | 0.180 |
Why?
|
| Zebrafish | 4 | 2018 | 3002 | 0.180 |
Why?
|
| Pregnancy Complications, Neoplastic | 2 | 2020 | 255 | 0.180 |
Why?
|
| Child | 32 | 2023 | 80086 | 0.180 |
Why?
|
| Melanoma | 2 | 2022 | 5704 | 0.180 |
Why?
|
| Microscopy, Electron | 7 | 2003 | 2560 | 0.180 |
Why?
|
| Histones | 3 | 2020 | 2577 | 0.180 |
Why?
|
| Treatment Outcome | 24 | 2023 | 64591 | 0.170 |
Why?
|
| DNA Mutational Analysis | 5 | 2018 | 4108 | 0.170 |
Why?
|
| Angiofibroma | 2 | 2001 | 55 | 0.170 |
Why?
|
| Homeodomain Proteins | 3 | 2021 | 2413 | 0.170 |
Why?
|
| Predictive Value of Tests | 8 | 2019 | 15257 | 0.170 |
Why?
|
| Vaginal Neoplasms | 2 | 2001 | 104 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2024 | 20551 | 0.170 |
Why?
|
| Protein Isoforms | 1 | 2024 | 1697 | 0.170 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2021 | 154 | 0.170 |
Why?
|
| Muscle Cells | 1 | 2020 | 194 | 0.160 |
Why?
|
| Neurofibroma | 1 | 1999 | 94 | 0.160 |
Why?
|
| Mesothelioma | 2 | 2022 | 807 | 0.160 |
Why?
|
| Florida | 1 | 2020 | 431 | 0.160 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2020 | 682 | 0.160 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 4923 | 0.160 |
Why?
|
| Myofibroblasts | 1 | 2020 | 208 | 0.160 |
Why?
|
| Adenoma | 3 | 2022 | 2157 | 0.160 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2019 | 101 | 0.160 |
Why?
|
| Skull Neoplasms | 1 | 2019 | 173 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2019 | 430 | 0.150 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2014 | 1114 | 0.150 |
Why?
|
| Genes, Retinoblastoma | 1 | 1998 | 125 | 0.150 |
Why?
|
| Materials Testing | 2 | 2018 | 864 | 0.150 |
Why?
|
| Pyridines | 2 | 2024 | 2868 | 0.150 |
Why?
|
| Facial Bones | 1 | 2019 | 208 | 0.150 |
Why?
|
| Hemangioendothelioma, Epithelioid | 2 | 2013 | 53 | 0.150 |
Why?
|
| Peroxides | 1 | 2018 | 74 | 0.150 |
Why?
|
| Mesoderm | 1 | 2001 | 673 | 0.150 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2020 | 502 | 0.150 |
Why?
|
| Photons | 2 | 2014 | 585 | 0.150 |
Why?
|
| Fractures, Spontaneous | 1 | 2019 | 231 | 0.150 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2003 | 952 | 0.150 |
Why?
|
| Hyperplasia | 1 | 2021 | 1153 | 0.150 |
Why?
|
| Immunoenzyme Techniques | 6 | 2001 | 1704 | 0.150 |
Why?
|
| RANK Ligand | 1 | 2019 | 318 | 0.140 |
Why?
|
| Muscle Neoplasms | 1 | 1998 | 130 | 0.140 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 305 | 0.140 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1089 | 0.140 |
Why?
|
| Muscular Diseases | 1 | 2002 | 553 | 0.140 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 269 | 0.140 |
Why?
|
| Myofibroma | 1 | 2017 | 45 | 0.140 |
Why?
|
| Neoplasm Proteins | 6 | 2021 | 3610 | 0.140 |
Why?
|
| Hematologic Diseases | 1 | 2021 | 496 | 0.140 |
Why?
|
| Fibroma, Desmoplastic | 1 | 1996 | 6 | 0.140 |
Why?
|
| Lumbar Vertebrae | 3 | 2015 | 1872 | 0.140 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2018 | 234 | 0.140 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2016 | 56 | 0.140 |
Why?
|
| Sclerosis | 2 | 2014 | 210 | 0.140 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2018 | 200 | 0.140 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2017 | 62 | 0.140 |
Why?
|
| T-Box Domain Proteins | 2 | 2023 | 468 | 0.140 |
Why?
|
| Nuclear Proteins | 2 | 2021 | 5794 | 0.130 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2019 | 502 | 0.130 |
Why?
|
| Smooth Muscle Tumor | 1 | 1996 | 63 | 0.130 |
Why?
|
| Stapes | 1 | 2015 | 89 | 0.130 |
Why?
|
| Lipomatosis | 1 | 2016 | 112 | 0.130 |
Why?
|
| Osteomyelitis | 2 | 2016 | 407 | 0.130 |
Why?
|
| HLA Antigens | 1 | 2021 | 1371 | 0.130 |
Why?
|
| Gene Amplification | 1 | 2020 | 1086 | 0.130 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2015 | 141 | 0.130 |
Why?
|
| Neoplasm, Residual | 4 | 2014 | 1008 | 0.130 |
Why?
|
| Osteoblasts | 1 | 2021 | 1143 | 0.120 |
Why?
|
| Salivary Gland Neoplasms | 2 | 2017 | 304 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 2 | 2022 | 2018 | 0.120 |
Why?
|
| Mandibular Diseases | 1 | 2016 | 119 | 0.120 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2016 | 256 | 0.120 |
Why?
|
| Retrospective Studies | 27 | 2024 | 80430 | 0.120 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2019 | 569 | 0.120 |
Why?
|
| Intestines | 2 | 2016 | 1909 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 4567 | 0.120 |
Why?
|
| Repressor Proteins | 4 | 2022 | 2978 | 0.120 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2015 | 101 | 0.120 |
Why?
|
| MicroRNAs | 3 | 2019 | 3796 | 0.120 |
Why?
|
| Amyloidosis | 1 | 2021 | 817 | 0.120 |
Why?
|
| Radiotherapy, Adjuvant | 7 | 2015 | 1784 | 0.120 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 1355 | 0.120 |
Why?
|
| Biopsy, Fine-Needle | 3 | 2018 | 1118 | 0.120 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2014 | 47 | 0.120 |
Why?
|
| Fibrous Dysplasia, Monostotic | 1 | 2014 | 8 | 0.120 |
Why?
|
| Thigh | 1 | 1995 | 241 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 3 | 2021 | 5778 | 0.120 |
Why?
|
| Telepathology | 1 | 2014 | 77 | 0.120 |
Why?
|
| Cell Line, Tumor | 11 | 2024 | 16945 | 0.120 |
Why?
|
| Activating Transcription Factor 1 | 1 | 2013 | 26 | 0.110 |
Why?
|
| Zebrafish Proteins | 2 | 2018 | 1012 | 0.110 |
Why?
|
| Knee | 1 | 1995 | 279 | 0.110 |
Why?
|
| Cecal Neoplasms | 1 | 1993 | 26 | 0.110 |
Why?
|
| Telomerase | 1 | 2019 | 745 | 0.110 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2010 | 2047 | 0.110 |
Why?
|
| Fibrosis | 4 | 2018 | 2048 | 0.110 |
Why?
|
| Survival Rate | 9 | 2019 | 12698 | 0.110 |
Why?
|
| Ossification, Heterotopic | 2 | 2009 | 235 | 0.110 |
Why?
|
| Vulvar Diseases | 2 | 2008 | 62 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 4 | 2018 | 3587 | 0.110 |
Why?
|
| Shoulder | 1 | 1995 | 299 | 0.110 |
Why?
|
| Limb Salvage | 1 | 2016 | 480 | 0.110 |
Why?
|
| Fetal Proteins | 1 | 2013 | 97 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 2 | 2018 | 1347 | 0.110 |
Why?
|
| Debridement | 1 | 2016 | 493 | 0.110 |
Why?
|
| Mast-Cell Sarcoma | 1 | 2012 | 46 | 0.110 |
Why?
|
| RNA | 2 | 2020 | 2721 | 0.110 |
Why?
|
| Histiocytes | 2 | 2010 | 98 | 0.110 |
Why?
|
| Membrane Proteins | 4 | 2018 | 7849 | 0.110 |
Why?
|
| Radiotherapy, Conformal | 2 | 2014 | 548 | 0.110 |
Why?
|
| Myxosarcoma | 1 | 2012 | 11 | 0.110 |
Why?
|
| Stem Cell Niche | 2 | 2016 | 345 | 0.110 |
Why?
|
| Furans | 1 | 2014 | 200 | 0.110 |
Why?
|
| Radiography | 5 | 2010 | 6963 | 0.100 |
Why?
|
| Stem Cells | 3 | 2016 | 3522 | 0.100 |
Why?
|
| Combined Modality Therapy | 9 | 2016 | 8522 | 0.100 |
Why?
|
| Appendix | 1 | 1993 | 109 | 0.100 |
Why?
|
| Fibronectins | 1 | 2016 | 723 | 0.100 |
Why?
|
| Intermediate Filaments | 2 | 2010 | 172 | 0.100 |
Why?
|
| Radiotherapy Dosage | 7 | 2016 | 2898 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2013 | 346 | 0.100 |
Why?
|
| Arthroplasty, Replacement | 2 | 2018 | 310 | 0.100 |
Why?
|
| Osteolysis | 1 | 2014 | 275 | 0.100 |
Why?
|
| Mesentery | 2 | 2022 | 202 | 0.100 |
Why?
|
| Antineoplastic Agents | 7 | 2019 | 13616 | 0.100 |
Why?
|
| Remote Consultation | 1 | 2014 | 237 | 0.100 |
Why?
|
| Terminology as Topic | 2 | 1996 | 1534 | 0.100 |
Why?
|
| Paneth Cells | 1 | 2012 | 98 | 0.100 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2015 | 3159 | 0.100 |
Why?
|
| Follow-Up Studies | 15 | 2023 | 39078 | 0.100 |
Why?
|
| Chondrosarcoma, Mesenchymal | 1 | 2011 | 12 | 0.100 |
Why?
|
| Necrosis | 2 | 2014 | 1604 | 0.100 |
Why?
|
| Jaw Neoplasms | 1 | 2012 | 70 | 0.100 |
Why?
|
| Muscle Development | 1 | 2013 | 259 | 0.100 |
Why?
|
| Molecular Biology | 1 | 2015 | 580 | 0.100 |
Why?
|
| Joint Loose Bodies | 1 | 2011 | 19 | 0.090 |
Why?
|
| Hemosiderin | 1 | 2011 | 41 | 0.090 |
Why?
|
| Thyroid Function Tests | 1 | 2012 | 289 | 0.090 |
Why?
|
| Placenta | 1 | 2020 | 1704 | 0.090 |
Why?
|
| Synovitis, Pigmented Villonodular | 1 | 2011 | 32 | 0.090 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2011 | 135 | 0.090 |
Why?
|
| Pelvis | 1 | 2015 | 732 | 0.090 |
Why?
|
| Temporal Bone | 1 | 2015 | 683 | 0.090 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2013 | 611 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 637 | 0.090 |
Why?
|
| Oncogenes | 2 | 2014 | 1223 | 0.090 |
Why?
|
| Adenocarcinoma, Mucinous | 2 | 1993 | 517 | 0.090 |
Why?
|
| Bone Marrow | 1 | 2021 | 2907 | 0.090 |
Why?
|
| Antioxidants | 1 | 2018 | 1670 | 0.090 |
Why?
|
| Maxillary Neoplasms | 1 | 2010 | 47 | 0.090 |
Why?
|
| Ankle | 1 | 2013 | 349 | 0.090 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2010 | 73 | 0.090 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 2017 | 0.090 |
Why?
|
| Gene Dosage | 2 | 2013 | 1218 | 0.090 |
Why?
|
| Cytoplasmic Structures | 1 | 2010 | 21 | 0.090 |
Why?
|
| Fatal Outcome | 4 | 2006 | 1832 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2019 | 3734 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2018 | 2870 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2014 | 570 | 0.090 |
Why?
|
| Disease Models, Animal | 5 | 2014 | 18216 | 0.090 |
Why?
|
| Desmosomes | 1 | 2010 | 72 | 0.090 |
Why?
|
| Thyroiditis | 1 | 2010 | 86 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 633 | 0.090 |
Why?
|
| Tuberous Sclerosis | 1 | 2018 | 1030 | 0.090 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2011 | 302 | 0.090 |
Why?
|
| Crystallization | 1 | 2011 | 533 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2018 | 6471 | 0.090 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2010 | 223 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 1889 | 0.080 |
Why?
|
| Radiology | 1 | 2023 | 2112 | 0.080 |
Why?
|
| Tumor Burden | 4 | 2020 | 1887 | 0.080 |
Why?
|
| Phenotype | 4 | 2020 | 16585 | 0.080 |
Why?
|
| Appendiceal Neoplasms | 1 | 1991 | 155 | 0.080 |
Why?
|
| Synovitis | 1 | 2011 | 221 | 0.080 |
Why?
|
| Receptors, Growth Factor | 1 | 2010 | 326 | 0.080 |
Why?
|
| Histone Acetyltransferases | 1 | 2011 | 336 | 0.080 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 2 | 1999 | 330 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2013 | 727 | 0.080 |
Why?
|
| Signal Transduction | 5 | 2018 | 23397 | 0.080 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 1874 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2013 | 1741 | 0.080 |
Why?
|
| Spinal Diseases | 1 | 2014 | 564 | 0.080 |
Why?
|
| Genotype | 2 | 2013 | 12976 | 0.080 |
Why?
|
| Immune Tolerance | 3 | 2003 | 2300 | 0.080 |
Why?
|
| Gene Expression Profiling | 4 | 2014 | 9410 | 0.080 |
Why?
|
| SOX9 Transcription Factor | 1 | 2009 | 145 | 0.080 |
Why?
|
| Adipocytes | 1 | 1995 | 1192 | 0.080 |
Why?
|
| Paranasal Sinuses | 1 | 2011 | 265 | 0.080 |
Why?
|
| Stromal Cells | 3 | 2012 | 1330 | 0.080 |
Why?
|
| Organelles | 2 | 2001 | 266 | 0.080 |
Why?
|
| DNA, Neoplasm | 1 | 1993 | 1745 | 0.080 |
Why?
|
| Proteoglycans | 1 | 2011 | 803 | 0.080 |
Why?
|
| Infant | 6 | 2023 | 36183 | 0.080 |
Why?
|
| Cell Proliferation | 6 | 2018 | 10425 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2014 | 2860 | 0.070 |
Why?
|
| Neoplasm Staging | 7 | 2023 | 11096 | 0.070 |
Why?
|
| Respiratory System | 1 | 2011 | 563 | 0.070 |
Why?
|
| RNA, Neoplasm | 2 | 2014 | 749 | 0.070 |
Why?
|
| Cell Count | 3 | 2018 | 1834 | 0.070 |
Why?
|
| Boston | 1 | 2020 | 9326 | 0.070 |
Why?
|
| Immobilization | 1 | 2008 | 227 | 0.070 |
Why?
|
| Lymphangiosarcoma | 1 | 2006 | 14 | 0.070 |
Why?
|
| Inclusion Bodies | 1 | 2008 | 281 | 0.070 |
Why?
|
| Thyroid Diseases | 1 | 2010 | 386 | 0.070 |
Why?
|
| Antigens, CD34 | 2 | 1999 | 658 | 0.070 |
Why?
|
| Fibroblasts | 3 | 2011 | 4106 | 0.070 |
Why?
|
| Amiodarone | 1 | 2008 | 216 | 0.070 |
Why?
|
| Chromosome Aberrations | 2 | 2011 | 1771 | 0.070 |
Why?
|
| Neoplasm Metastasis | 5 | 2018 | 4903 | 0.070 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2013 | 616 | 0.070 |
Why?
|
| Doxorubicin | 5 | 2014 | 2215 | 0.070 |
Why?
|
| Brachytherapy | 1 | 2014 | 1223 | 0.070 |
Why?
|
| Hamartoma | 1 | 2009 | 235 | 0.070 |
Why?
|
| Tendons | 1 | 2011 | 558 | 0.070 |
Why?
|
| Eosinophilia | 1 | 2011 | 560 | 0.070 |
Why?
|
| Animals | 24 | 2024 | 168253 | 0.060 |
Why?
|
| Muscles | 2 | 2009 | 1575 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2006 | 255 | 0.060 |
Why?
|
| Survival Analysis | 5 | 2018 | 10075 | 0.060 |
Why?
|
| Prosthesis Failure | 1 | 2011 | 1203 | 0.060 |
Why?
|
| Neoplasm Transplantation | 3 | 2018 | 2014 | 0.060 |
Why?
|
| Low Back Pain | 1 | 2014 | 982 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 4020 | 0.060 |
Why?
|
| STAT3 Transcription Factor | 1 | 2009 | 870 | 0.060 |
Why?
|
| Chondrocytes | 2 | 2001 | 792 | 0.060 |
Why?
|
| Pyrimidines | 2 | 2014 | 3024 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2014 | 2453 | 0.060 |
Why?
|
| Energy Intake | 1 | 2012 | 2134 | 0.060 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2009 | 732 | 0.060 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2008 | 776 | 0.060 |
Why?
|
| Edema | 1 | 2008 | 769 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 17854 | 0.060 |
Why?
|
| Epithelium | 2 | 2001 | 1603 | 0.060 |
Why?
|
| Hysterectomy | 2 | 2020 | 857 | 0.060 |
Why?
|
| Histiocytoma, Benign Fibrous | 2 | 2001 | 64 | 0.060 |
Why?
|
| Lung Neoplasms | 6 | 2021 | 13312 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 2529 | 0.060 |
Why?
|
| Simplexvirus | 1 | 2007 | 803 | 0.060 |
Why?
|
| Rabbits | 3 | 2018 | 4780 | 0.060 |
Why?
|
| WT1 Proteins | 1 | 2024 | 184 | 0.060 |
Why?
|
| Gout | 1 | 2011 | 623 | 0.060 |
Why?
|
| Hindlimb | 2 | 2003 | 509 | 0.060 |
Why?
|
| Carcinoma, Islet Cell | 1 | 2003 | 21 | 0.050 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2010 | 801 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2011 | 1994 | 0.050 |
Why?
|
| Neoplasms, Fibrous Tissue | 1 | 2003 | 20 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2024 | 3590 | 0.050 |
Why?
|
| Time Factors | 7 | 2016 | 39947 | 0.050 |
Why?
|
| Cell Division | 4 | 2012 | 4461 | 0.050 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2022 | 35 | 0.050 |
Why?
|
| Pyrroles | 1 | 2009 | 1126 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5663 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2015 | 4936 | 0.050 |
Why?
|
| Mediastinum | 1 | 2023 | 267 | 0.050 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2022 | 199 | 0.050 |
Why?
|
| Chromatin | 2 | 2024 | 2951 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 5 | 2014 | 6128 | 0.050 |
Why?
|
| Oncolytic Virotherapy | 1 | 2007 | 516 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 3346 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 4 | 2012 | 3512 | 0.050 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 1264 | 0.050 |
Why?
|
| Lipids | 1 | 2012 | 3342 | 0.050 |
Why?
|
| Omentum | 1 | 2002 | 168 | 0.050 |
Why?
|
| Isochromosomes | 1 | 2000 | 16 | 0.050 |
Why?
|
| Indoles | 1 | 2009 | 1833 | 0.050 |
Why?
|
| Cisplatin | 3 | 2014 | 1647 | 0.050 |
Why?
|
| beta 2-Microglobulin | 1 | 2021 | 329 | 0.050 |
Why?
|
| Collagen Type I | 1 | 2024 | 616 | 0.050 |
Why?
|
| Skull Base | 1 | 2023 | 292 | 0.040 |
Why?
|
| Tissue Transplantation | 1 | 2001 | 128 | 0.040 |
Why?
|
| Receptors, Estrogen | 2 | 2001 | 2204 | 0.040 |
Why?
|
| Sirolimus | 3 | 2013 | 1533 | 0.040 |
Why?
|
| Intercellular Junctions | 1 | 2001 | 195 | 0.040 |
Why?
|
| Curettage | 1 | 2020 | 73 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 3541 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2002 | 418 | 0.040 |
Why?
|
| Cytogenetic Analysis | 2 | 2011 | 270 | 0.040 |
Why?
|
| Mice | 11 | 2024 | 81402 | 0.040 |
Why?
|
| Skin Transplantation | 2 | 2003 | 1083 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2012 | 11729 | 0.040 |
Why?
|
| Fasciitis | 2 | 2000 | 67 | 0.040 |
Why?
|
| Metaplasia | 1 | 2001 | 321 | 0.040 |
Why?
|
| Ulna | 1 | 2001 | 134 | 0.040 |
Why?
|
| Hyalin | 1 | 1999 | 34 | 0.040 |
Why?
|
| Proteins | 2 | 2012 | 6033 | 0.040 |
Why?
|
| Chimera | 1 | 2001 | 453 | 0.040 |
Why?
|
| Tissue Array Analysis | 2 | 2013 | 550 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2014 | 897 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 15867 | 0.040 |
Why?
|
| Genes, p16 | 1 | 1999 | 159 | 0.040 |
Why?
|
| Vascular Neoplasms | 1 | 2001 | 166 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2023 | 613 | 0.040 |
Why?
|
| Piperazines | 2 | 2024 | 2519 | 0.040 |
Why?
|
| Analysis of Variance | 4 | 2012 | 6230 | 0.040 |
Why?
|
| Mandible | 1 | 2004 | 753 | 0.040 |
Why?
|
| Transplantation Immunology | 1 | 2001 | 532 | 0.040 |
Why?
|
| Musculoskeletal System | 1 | 2001 | 188 | 0.040 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 1998 | 122 | 0.040 |
Why?
|
| Syndrome | 3 | 2015 | 3267 | 0.040 |
Why?
|
| Recurrence | 3 | 2022 | 8466 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2014 | 2058 | 0.040 |
Why?
|
| Animals, Genetically Modified | 2 | 2013 | 1561 | 0.040 |
Why?
|
| Proto-Oncogenes | 1 | 2019 | 321 | 0.040 |
Why?
|
| Lung Diseases | 1 | 2008 | 1909 | 0.040 |
Why?
|
| Information Storage and Retrieval | 1 | 2004 | 819 | 0.040 |
Why?
|
| Glucose | 1 | 2010 | 4342 | 0.040 |
Why?
|
| Models, Animal | 2 | 2003 | 2111 | 0.040 |
Why?
|
| Protons | 1 | 2023 | 1115 | 0.040 |
Why?
|
| Endometrium | 1 | 2001 | 404 | 0.040 |
Why?
|
| Endoplasmic Reticulum, Rough | 1 | 1997 | 21 | 0.040 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2018 | 161 | 0.040 |
Why?
|
| Wilms Tumor | 1 | 2000 | 379 | 0.040 |
Why?
|
| Random Allocation | 2 | 2014 | 2388 | 0.040 |
Why?
|
| Buttocks | 1 | 1997 | 111 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2014 | 41366 | 0.040 |
Why?
|
| Tomography | 1 | 1999 | 411 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2013 | 6086 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2010 | 716 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 7424 | 0.040 |
Why?
|
| Organic Chemicals | 1 | 2018 | 211 | 0.040 |
Why?
|
| Vacuoles | 2 | 2012 | 228 | 0.030 |
Why?
|
| Mitochondria | 1 | 2010 | 3624 | 0.030 |
Why?
|
| Radiotherapy | 2 | 2008 | 1498 | 0.030 |
Why?
|
| DNA | 2 | 2022 | 7208 | 0.030 |
Why?
|
| Abdominal Muscles | 1 | 1997 | 168 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2000 | 926 | 0.030 |
Why?
|
| DNA Methylation | 2 | 2022 | 4383 | 0.030 |
Why?
|
| Amyloid | 1 | 2021 | 840 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 802 | 0.030 |
Why?
|
| PPAR delta | 1 | 2016 | 40 | 0.030 |
Why?
|
| Endothelial Growth Factors | 1 | 1998 | 673 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 1998 | 659 | 0.030 |
Why?
|
| Proportional Hazards Models | 3 | 2015 | 12429 | 0.030 |
Why?
|
| Ovariectomy | 1 | 1998 | 614 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2024 | 1739 | 0.030 |
Why?
|
| Germany | 1 | 2018 | 873 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2018 | 2188 | 0.030 |
Why?
|
| Hand | 1 | 2021 | 902 | 0.030 |
Why?
|
| Genes, APC | 1 | 2016 | 144 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2020 | 697 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2010 | 2468 | 0.030 |
Why?
|
| Lymphokines | 1 | 1998 | 927 | 0.030 |
Why?
|
| Pleural Neoplasms | 1 | 2000 | 609 | 0.030 |
Why?
|
| Swine, Miniature | 3 | 2002 | 961 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 1959 | 0.030 |
Why?
|
| Karyotyping | 2 | 2011 | 1171 | 0.030 |
Why?
|
| Cell Nucleolus | 1 | 2015 | 156 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1998 | 653 | 0.030 |
Why?
|
| Hearing Loss, Conductive | 1 | 2015 | 159 | 0.030 |
Why?
|
| Pain Measurement | 2 | 2016 | 3546 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 1998 | 556 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2002 | 2693 | 0.030 |
Why?
|
| Multiprotein Complexes | 2 | 2012 | 1119 | 0.030 |
Why?
|
| Binding Sites | 1 | 2023 | 6042 | 0.030 |
Why?
|
| Peripheral Nerves | 1 | 1998 | 479 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2019 | 1091 | 0.030 |
Why?
|
| Homozygote | 1 | 2018 | 1794 | 0.030 |
Why?
|
| Base Sequence | 2 | 2014 | 12449 | 0.030 |
Why?
|
| Myosin Light Chains | 1 | 2013 | 121 | 0.030 |
Why?
|
| Paired Box Transcription Factors | 1 | 2014 | 206 | 0.030 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2018 | 491 | 0.030 |
Why?
|
| Exons | 1 | 2019 | 2392 | 0.030 |
Why?
|
| Transplantation, Homologous | 4 | 2003 | 4808 | 0.030 |
Why?
|
| Ploidies | 1 | 1993 | 284 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2001 | 2610 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2022 | 2858 | 0.030 |
Why?
|
| Mesna | 1 | 2012 | 62 | 0.030 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1999 | 779 | 0.030 |
Why?
|
| Gamma Rays | 1 | 2014 | 318 | 0.030 |
Why?
|
| Cardiac Myosins | 1 | 2013 | 128 | 0.030 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2012 | 38 | 0.030 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2012 | 16 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2021 | 9176 | 0.030 |
Why?
|
| Incidence | 4 | 2015 | 21322 | 0.030 |
Why?
|
| Neurofibrillary Tangles | 1 | 1995 | 457 | 0.030 |
Why?
|
| S Phase | 1 | 1993 | 421 | 0.030 |
Why?
|
| Ifosfamide | 1 | 2012 | 232 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2014 | 944 | 0.030 |
Why?
|
| Reference Values | 1 | 1999 | 4921 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1998 | 1492 | 0.020 |
Why?
|
| Flow Cytometry | 3 | 2002 | 5865 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2021 | 1795 | 0.020 |
Why?
|
| Osteoclasts | 1 | 2016 | 711 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2014 | 450 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 22121 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2001 | 2444 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2021 | 2539 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2004 | 3685 | 0.020 |
Why?
|
| Cartilage, Articular | 1 | 1999 | 1096 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 1998 | 1069 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 1996 | 1128 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 316 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2018 | 1440 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2016 | 2281 | 0.020 |
Why?
|
| Transfection | 1 | 2019 | 5776 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 3446 | 0.020 |
Why?
|
| Iceland | 1 | 1991 | 184 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2018 | 1272 | 0.020 |
Why?
|
| Obesity | 2 | 2016 | 12918 | 0.020 |
Why?
|
| Hemosiderosis | 1 | 2011 | 66 | 0.020 |
Why?
|
| Cytodiagnosis | 1 | 2015 | 447 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2014 | 516 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2022 | 2318 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2023 | 3541 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2012 | 276 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2012 | 468 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2013 | 712 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 867 | 0.020 |
Why?
|
| Lymphoma | 1 | 1999 | 1901 | 0.020 |
Why?
|
| Eye Proteins | 1 | 2014 | 633 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 1824 | 0.020 |
Why?
|
| Leukemia | 1 | 2018 | 1522 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3782 | 0.020 |
Why?
|
| Dioxoles | 1 | 2010 | 95 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 3428 | 0.020 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2010 | 81 | 0.020 |
Why?
|
| Cell Size | 1 | 2012 | 624 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2021 | 2725 | 0.020 |
Why?
|
| Decision Making | 1 | 2004 | 3923 | 0.020 |
Why?
|
| Particle Size | 1 | 2014 | 1643 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2019 | 4277 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2014 | 1755 | 0.020 |
Why?
|
| Caloric Restriction | 1 | 2012 | 299 | 0.020 |
Why?
|
| Xanthenes | 1 | 2009 | 72 | 0.020 |
Why?
|
| Workflow | 1 | 2014 | 851 | 0.020 |
Why?
|
| Organoids | 1 | 2016 | 741 | 0.020 |
Why?
|
| Gene Expression | 2 | 2014 | 7582 | 0.020 |
Why?
|
| Dacarbazine | 1 | 2012 | 559 | 0.020 |
Why?
|
| Microscopy | 1 | 2014 | 886 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2014 | 2625 | 0.020 |
Why?
|
| Lacrimal Apparatus | 1 | 2011 | 223 | 0.020 |
Why?
|
| Mice, Transgenic | 3 | 2009 | 9533 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2019 | 14397 | 0.020 |
Why?
|
| Nasal Cavity | 1 | 2011 | 304 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2010 | 511 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2013 | 1956 | 0.020 |
Why?
|
| Polyradiculoneuropathy | 1 | 2008 | 65 | 0.020 |
Why?
|
| Lung Abscess | 1 | 2008 | 40 | 0.020 |
Why?
|
| Age of Onset | 1 | 2016 | 3302 | 0.020 |
Why?
|
| Oral Surgical Procedures | 1 | 2010 | 166 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2010 | 5031 | 0.020 |
Why?
|
| Pain | 1 | 2004 | 5075 | 0.020 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2009 | 184 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2019 | 1636 | 0.020 |
Why?
|
| Cadherins | 1 | 2013 | 904 | 0.020 |
Why?
|
| Osteotomy | 1 | 2014 | 837 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2010 | 572 | 0.020 |
Why?
|
| Schwann Cells | 1 | 2009 | 197 | 0.020 |
Why?
|
| Observer Variation | 1 | 2014 | 2604 | 0.020 |
Why?
|
| Osteoarthritis, Knee | 1 | 1999 | 1241 | 0.020 |
Why?
|
| Feasibility Studies | 2 | 2014 | 5236 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 934 | 0.020 |
Why?
|
| Coccyx | 1 | 2007 | 13 | 0.020 |
Why?
|
| ras Proteins | 1 | 2013 | 1052 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 1363 | 0.020 |
Why?
|
| Swine | 3 | 2003 | 5915 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2014 | 1471 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2010 | 656 | 0.020 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2007 | 84 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 4575 | 0.020 |
Why?
|
| Upper Extremity | 1 | 2012 | 656 | 0.020 |
Why?
|
| Relative Biological Effectiveness | 1 | 2008 | 312 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1999 | 2204 | 0.020 |
Why?
|
| Benzamides | 1 | 2013 | 1370 | 0.020 |
Why?
|
| Keratin-19 | 1 | 2006 | 33 | 0.020 |
Why?
|
| Keratin-7 | 1 | 2006 | 55 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2007 | 384 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2014 | 1624 | 0.020 |
Why?
|
| Thyroidectomy | 1 | 2012 | 907 | 0.020 |
Why?
|
| Pregnancy | 2 | 2020 | 29831 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 2911 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 544 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2008 | 479 | 0.020 |
Why?
|
| Microvessels | 1 | 2010 | 574 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2852 | 0.020 |
Why?
|
| Age Factors | 2 | 2013 | 18379 | 0.020 |
Why?
|
| Chylothorax | 1 | 2006 | 83 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2010 | 1870 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2010 | 719 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2003 | 5359 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 5806 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 1994 | 2061 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 20078 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3777 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2020 | 7948 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2011 | 2612 | 0.020 |
Why?
|
| Skin Neoplasms | 3 | 2010 | 5815 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 11095 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2007 | 1122 | 0.010 |
Why?
|
| Longevity | 1 | 2012 | 1062 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2014 | 12785 | 0.010 |
Why?
|
| Vasculitis | 1 | 2008 | 522 | 0.010 |
Why?
|
| Neoplasms | 1 | 2013 | 22083 | 0.010 |
Why?
|
| Lower Extremity | 1 | 2012 | 1199 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2011 | 1165 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2011 | 2115 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2009 | 2642 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1999 | 3759 | 0.010 |
Why?
|
| Regeneration | 1 | 2012 | 1508 | 0.010 |
Why?
|
| Plasminogen | 1 | 2003 | 146 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 1994 | 2656 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 1667 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2805 | 0.010 |
Why?
|
| United States | 3 | 2016 | 72202 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2014 | 54339 | 0.010 |
Why?
|
| Protein Binding | 1 | 2014 | 9340 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 14661 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 17639 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2012 | 4000 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 1995 | 3835 | 0.010 |
Why?
|
| Mitotic Index | 1 | 2001 | 161 | 0.010 |
Why?
|
| Graft Survival | 2 | 2002 | 3806 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2016 | 9309 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2009 | 2242 | 0.010 |
Why?
|
| Abdominal Neoplasms | 1 | 2002 | 286 | 0.010 |
Why?
|
| Neurofibromatosis 2 | 1 | 2004 | 385 | 0.010 |
Why?
|
| Software | 1 | 2014 | 4426 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2008 | 1817 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2022 | 23953 | 0.010 |
Why?
|
| Genome, Human | 1 | 2013 | 4423 | 0.010 |
Why?
|
| Histocompatibility | 1 | 2001 | 317 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 6475 | 0.010 |
Why?
|
| Interferometry | 1 | 1999 | 100 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10538 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1999 | 26280 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2009 | 18955 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2007 | 2008 | 0.010 |
Why?
|
| Patient Selection | 1 | 2011 | 4240 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 2803 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2001 | 778 | 0.010 |
Why?
|
| Infrared Rays | 1 | 1999 | 247 | 0.010 |
Why?
|
| Endothelium | 1 | 2001 | 765 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2007 | 4116 | 0.010 |
Why?
|
| Microcirculation | 1 | 2003 | 1269 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 2001 | 927 | 0.010 |
Why?
|
| Breast Neoplasms | 2 | 2007 | 20985 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2007 | 2646 | 0.010 |
Why?
|
| Apoptosis | 1 | 2014 | 9468 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2000 | 559 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1998 | 462 | 0.010 |
Why?
|
| Postoperative Complications | 2 | 2010 | 15627 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 5662 | 0.010 |
Why?
|
| Neurofibromin 2 | 1 | 1998 | 270 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 2000 | 342 | 0.010 |
Why?
|
| Skin | 2 | 2003 | 4474 | 0.010 |
Why?
|
| Osteonecrosis | 1 | 1999 | 229 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1998 | 748 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2001 | 1608 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2001 | 2265 | 0.010 |
Why?
|
| Disease Progression | 1 | 2013 | 13484 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2003 | 3603 | 0.010 |
Why?
|
| Cause of Death | 1 | 2007 | 3686 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 1998 | 836 | 0.010 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1998 | 507 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2000 | 1511 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 1998 | 336 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 26063 | 0.010 |
Why?
|
| Tooth Diseases | 1 | 1995 | 74 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1998 | 1528 | 0.010 |
Why?
|
| Failure to Thrive | 1 | 1995 | 140 | 0.010 |
Why?
|
| Nerve Fibers | 1 | 1998 | 708 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 1994 | 11453 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 6525 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 1998 | 2060 | 0.010 |
Why?
|
| Hypercalcemia | 1 | 1995 | 423 | 0.010 |
Why?
|
| Palliative Care | 1 | 2007 | 3585 | 0.010 |
Why?
|
| Coronary Thrombosis | 1 | 1994 | 440 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 9003 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 4430 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1999 | 1406 | 0.010 |
Why?
|
| Endocarditis, Bacterial | 1 | 1994 | 444 | 0.010 |
Why?
|
| Orthopedic Procedures | 1 | 1999 | 1263 | 0.010 |
Why?
|
| Musculoskeletal Diseases | 1 | 1995 | 597 | 0.000 |
Why?
|
| Catheterization | 1 | 1994 | 1432 | 0.000 |
Why?
|
| Face | 1 | 1995 | 1020 | 0.000 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1994 | 1163 | 0.000 |
Why?
|
| Epithelial Cells | 1 | 2000 | 3661 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 4168 | 0.000 |
Why?
|
| Acute Disease | 1 | 1999 | 7230 | 0.000 |
Why?
|
| Brain | 1 | 1995 | 27060 | 0.000 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 1998 | 3486 | 0.000 |
Why?
|
| Wound Healing | 1 | 1998 | 2799 | 0.000 |
Why?
|
| Cell Line | 1 | 2001 | 15598 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 2002 | 4319 | 0.000 |
Why?
|
| Kidney Diseases | 1 | 1995 | 2093 | 0.000 |
Why?
|
| Dementia | 1 | 1995 | 2679 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1995 | 15476 | 0.000 |
Why?
|